Abstract
British Journal of Clinical PharmacologyVolume 17, Issue 4 p. 485-486 Free Access The effect of spironolactone on the liver microsomal enzyme system in patients. EE Ohnhaus, EE OhnhausSearch for more papers by this authorE Gerber-Taras, E Gerber-TarasSearch for more papers by this author EE Ohnhaus, EE OhnhausSearch for more papers by this authorE Gerber-Taras, E Gerber-TarasSearch for more papers by this author First published: April 1984 https://doi.org/10.1111/j.1365-2125.1984.tb02378.xCitations: 2AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinkedInRedditWechat No abstract is available for this article. References Feller, D. R. & Gerald, M. C. (1971). Interactions of spironolactone with hepatic microsomal drug metabolising systems. Biochem. Pharmac., 20, 1991– 2000. Huffman, D. H., Shoeman, D. W., Pentikäinen, P. & Azarnoff, D. L. (1973). The effect of spironolactone on antipyrine metabolism in man. Pharmacology, 10, 338– 344. Ohnhaus, E. E. & Park, B. K. (1979). Measurement of urinary 6β-hydroxycortisol excretion as an in vivo parameter in the clinical assessment of the microsomal enzyme inducing capacity of antipyrine, phenobarbitone and rifampicin. Eur. J. clin. Pharmac., 15, 139– 145. Talcott, R. E. & Stohs, S. J. (1972). Metabolism of aniline and hexobarbital by liver homogenates of spironolactone pretreated rats. J. pharm. Sci., 61, s296– 297. Taylor, S. A., Rawlins, M. D. & Smith, S. E. (1972). Spironolactone—a weak inducer in man. J. Pharm. Pharmac., 24, 578– 579. Citing Literature Volume17, Issue4April 1984Pages 485-486 ReferencesRelatedInformation
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
